title: Severe myelosuppression resulting from concurrent administration of granulocyte colony-stimulating factor and cytotoxic chemotherapy.
authors.affiliation: Hematology-Oncology Section, Hospital of the University of Pennsylvania, Philadelphia.
authors.forename: N J
authors.initials: NJ
authors.lastname: Meropol
authors.forename: L L
authors.initials: LL
authors.lastname: Miller
authors.forename: E L
authors.initials: EL
authors.lastname: Korn
authors.forename: L E
authors.initials: LE
authors.lastname: Braitman
authors.forename: M L
authors.initials: ML
authors.lastname: MacDermott
authors.forename: L M
authors.initials: LM
authors.lastname: Schuchter
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D001853:Bone Marrow / Q000187:drug effects*; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage / Q000009:adverse effects; D008875:Middle Aged
chemical_list: D016179:Granulocyte Colony-Stimulating Factor; D002955:Leucovorin; D005472:Fluorouracil